Yvonne Schrage

Assessment of Interobserver Variability and Histologic Parameters to Improve Reliability in Classification and Grading of Central Cartilaginous Tumors

D. Eefting, Yvonne Schrage, Maartje J. A. Geirnaerdt et al. · The American Journal of Surgical Pathology · 2008 · 258 citations

Medicine, Oncology, Pathology +12

Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment

Yvonne Schrage, Inge H. Briaire‐de Bruijn, Noel F.C.C. de Miranda et al. · Cancer Research · 2009 · 108 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma

Jules Lansu, Judith V.M.G. Bovée, Pètra M. Braam et al. · JAMA Oncology · 2020 · 104 citations · Full text

Medicine, Oncology, Surgery +16

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down‐regulation and p16 overexpression inhibit cell growth in vitro

Yvonne Schrage, Suzanne Lam, Aart G. Jochemsen et al. · Journal of Cellular and Molecular Medicine · 2008 · 99 citations · Full text

Medicine, Molecular Biology, Oncology +17

Cellular Radiosensitivity of Soft Tissue Sarcoma

Rick L. Haas, B.G.J. Floot, Astrid N. Scholten et al. · Radiation Research · 2021 · 87 citations

Medicine, Oncology, Radiation Oncology +17